E.g., 10/16/2019
E.g., 10/16/2019
Title Category Credit Event Date Pricesort ascending
Update Series (2016) Lesson 11: Surgical Treatment of SUI in 2016— What is the Role of the Mid-Urethral Sling? $0.00 For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2016 AUA Update Series—AUA's most popular self-study CME product.Concise, practical lessons on timely topicsState-of-the-art surgical techniquesAuthors are among the best in their specialtiesEarn up to 40 AMA PRA Category 1 Credits™
Integrating Care for Oncology Patients: Establishing a Multidisciplinary Oncology Clinic with Advanced Therapeutics Webcast 077IC (2019)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 This course will provide the framework to create a multidisciplinary clinic for the treatment of urologic malignancies, with representation of urologists, medical oncologists and additional specialists working together in a team-based approach. The course will focus on integration of advanced therapeutics including immune-based therapy where applicable in a multidisciplinary setting.
Immuno-Oncology: A Focus on Kidney Cancer Webcast (2018)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of adverse events, the AUA is producing a series of online activities for clinicians and other healthcare professionals. The 2018 series is comprised of a variety of activities, including four live webinars, webcasts and podcasts plus three podcast addressing the barriers to immunotherapy treatment of GU cancer. All activities are complimentary.
Best of AUA- BPH: Minimally Invasive/ Surgical Options for Treating mLUTS and BPH (2017) $0.00 This 90 minute FREE non-cme webinar focuses on the topic of BPH.  AUA’s Secretary, Dr. Manoj Monga, is joined by expert faculties Drs. Alexis E. Te, M.D. and Dicken Shiu-Chung Ko for an exciting program featuring didactic lectures on Minimally Invasive/Surgical Options for treating mLUTS and BPH, Medical Therapy with both Mono and Combination Therapy with agents such as alpha blockers, antimuscarinics, 5-alpha reductase inhibitors, PDE-5 inhibitors, as well as step-by-step reviews of surgical videos including: 
Urologic Robotic Surgery Online Course (2017)
    • 13.50 AMA PRA Category 1 Credit™
    • 13.50 Non-Physician Participation
$0.00 Member only benefit! Welcome to American Urological Association Education and Research, Inc (AUAER)'s online Urologic Robotic Surgery Course, developed by the AUAER Laparoscopic, Robotic Surgery and New Surgical Technology Committee to address the need for a national course/curriculum in urologic robotic surgery. About 80% of all prostatectomies in the USA for the treatment of prostate cancer are being performed with robotic assistance (Su LM. Robot-assisted radical prostatectomy: advances since 2005. Current Opinion in Urology. 20(2):130-5, 2010).
Update Series (2016) Lesson 28: Ketamine: Its Use and Abuse in Urological Practice $0.00 For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2016 AUA Update Series—AUA's most popular self-study CME product.Concise, practical lessons on timely topicsState-of-the-art surgical techniquesAuthors are among the best in their specialtiesEarn up to 40 AMA PRA Category 1 Credits™
Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer (2017)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The AUA developed the Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer initiative to include multiple educational interventions to improve the urologist, medical oncologist, and other healthcare provider's ability to care for patients with bladder cancer. These activities are designed to increase the clinician's competence in the application of new and emerging treatment options, including the sequencing and associated side effects of those options.
Update Series (2019) Lesson 10: Lynch Syndrome in the Perspective of the Urologist
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Now in its 38th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed in consultation with and edited by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology. 
Update Series (2019) Lesson 26: Management of Castration Resistant Prostate Cancer
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Now in its 38th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed in consultation with and edited by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.
Update Series (2015) Lesson 10: Clinical Stage I Testicular Cancer $0.00 For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015!
Clinical Investigations in the Treatment of Urothelial Carcinoma Podcast (2019)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients, the AUA is launching a series of podcast episodes designed to improve the ability of the urologist to care for patients with prostate, bladder and kidney cancers. These activities are designed to increase the clinician’s competence in the application of new and emerging treatment options, including their mechanism of action and associated side effects.
Update Series (2019) Lesson 2: Evaluation and Management of Posterior Urethral Stenosis after Prostate Cancer Therapy
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Now in its 38th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed in consultation with and edited by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology. 
Update Series (2015) Lesson 26: Stents and Catheters—What’s New? $0.00 For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015!
Update Series (2016) Lesson 12: Gynecologic Evaluation before Female Pelvic Reconstructive Surgery $0.00 For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2016 AUA Update Series—AUA's most popular self-study CME product.Concise, practical lessons on timely topicsState-of-the-art surgical techniquesAuthors are among the best in their specialtiesEarn up to 40 AMA PRA Category 1 Credits™
Advanced Overactive Bladder Therapies: What to Do When 1st & 2nd Line Therapies Don’t Work Webcast 076IC (2019)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 This course would aim to discuss all guidelines-approved 3rd line therapies for the treatment of overactive bladder (OAB). Case–based discussion will be used adjunctively to illustrate how best to select patients in varying clinical scenarios and how to optimally counsel a patient on each of the available modalities, including onabotulinumtoxinA injection of the bladder, tibial nerve stimulation, and sacral nerve stimulation (SNS). Emerging therapies in neuromodulation will also be introduced.

Pages